[go: up one dir, main page]

MX2016014868A - Metodos para secar por congelacion y rehidratar productos biologicos. - Google Patents

Metodos para secar por congelacion y rehidratar productos biologicos.

Info

Publication number
MX2016014868A
MX2016014868A MX2016014868A MX2016014868A MX2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A
Authority
MX
Mexico
Prior art keywords
methods
rehydate
freezing
dry
cells
Prior art date
Application number
MX2016014868A
Other languages
English (en)
Inventor
Christophe Audonnet Jean-
Yves Henri Jean Genin Noel
Roy Didier
Seche Edouard
Gervais Patrick
KHALDI-PLASSART Samira
Useo Romain
De Coninck Joëlle
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MX2016014868A publication Critical patent/MX2016014868A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona generalmente a los campos de inmunología y tecnología de vacunas. Más específicamente, la presente invención se relaciona a métodos para secar por congelación preparaciones biológicas, que incluyen péptidos, antígenos, anticuerpos, y especialmente, células. De manera importante, los métodos descritos preservan la viabilidad, infectividad e inmunogenicidad de células de la Apicomplexa phylum, la familia Sarcocystidae, y en particular, células del género Toxoplasma.
MX2016014868A 2014-05-14 2015-05-13 Metodos para secar por congelacion y rehidratar productos biologicos. MX2016014868A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14168327 2014-05-14
PCT/US2015/030588 WO2015175672A1 (en) 2014-05-14 2015-05-13 Methods for freeze-drying and rehydrating biologics

Publications (1)

Publication Number Publication Date
MX2016014868A true MX2016014868A (es) 2017-07-19

Family

ID=50771060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016014868A MX2016014868A (es) 2014-05-14 2015-05-13 Metodos para secar por congelacion y rehidratar productos biologicos.

Country Status (7)

Country Link
US (1) US10632182B2 (es)
EP (1) EP3142486A1 (es)
AU (2) AU2015259221B2 (es)
CA (1) CA2948845C (es)
MX (1) MX2016014868A (es)
NZ (2) NZ726315A (es)
WO (1) WO2015175672A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3942931A1 (en) 2014-06-10 2022-01-26 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
ES3037826T3 (en) 2015-12-08 2025-10-07 Biomatrica Inc Reduction of erythrocyte sedimentation rate
CN106047812B (zh) * 2016-05-25 2018-08-03 上海赛立维生物科技有限公司 肿瘤组织冻存、复苏试剂盒及其处理方法
WO2018067647A1 (en) 2016-10-05 2018-04-12 Zoetis Services Llc Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
US11078521B2 (en) 2016-10-24 2021-08-03 Biomatrica, Inc. Stabilization of nucleic acids on paper
WO2020030572A1 (en) * 2018-08-07 2020-02-13 Glaxosmithkline Biologicals Sa Processes and vaccines
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
CN118165944A (zh) * 2024-03-15 2024-06-11 武汉格瑞农生物科技有限公司 一种沙门氏菌噬菌体冻干保护剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3783098A (en) 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3915794A (en) 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US4000256A (en) 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
JPH05506457A (ja) 1991-02-15 1993-09-22 クライアファーム　コーポレイション 非哺乳類の有核細胞と血液物質の混合物の凍結乾燥及び再構成法
EP0826063A1 (en) 1995-04-25 1998-03-04 Vical Incorporated Single-vial formulations of dna/lipid complexes
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
US6017537A (en) 1998-12-18 2000-01-25 Connaught Laboratories, Inc. Formyl methionyl peptide vaccine adjuvant
FR2864966B1 (fr) 2004-01-13 2006-05-05 Agronomique Inst Nat Rech Souches vaccinales d'apicomplexes de la famille des sarcocystidae.
JP5270925B2 (ja) 2008-02-07 2013-08-21 雪印メグミルク株式会社 微生物保護剤及び微生物の凍結又は凍結乾燥菌体の製造方法
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
US20110262965A1 (en) * 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
BR112013003244B1 (pt) * 2010-08-13 2018-07-17 Advanced Bionutrition Corp composição seca estabilizante para material biológico, seu método de preparação, e formulação de carreamento oral
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
FR2994193B1 (fr) 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
FR2994096B1 (fr) 2012-08-02 2016-03-04 Vitamfero Utilisation de souches attenuees de parasites pour la prevention ou le traitement de pathologies associees a un apicomplexe

Also Published As

Publication number Publication date
US20170087230A1 (en) 2017-03-30
BR112016026418A2 (es) 2017-08-22
CA2948845A1 (en) 2015-11-19
AU2015259221B2 (en) 2018-03-15
CA2948845C (en) 2022-05-31
AU2018203679B2 (en) 2019-11-21
WO2015175672A1 (en) 2015-11-19
BR112016026418A8 (pt) 2022-06-28
EP3142486A1 (en) 2017-03-22
AU2018203679A1 (en) 2018-06-14
NZ741421A (en) 2023-05-26
US10632182B2 (en) 2020-04-28
AU2015259221A1 (en) 2016-12-01
NZ726315A (en) 2018-04-27

Similar Documents

Publication Publication Date Title
MX2016014868A (es) Metodos para secar por congelacion y rehidratar productos biologicos.
IL283058A (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
IL255631B (en) Compositions and methods for screening t cells with antigens for specific populations
CO2018011804A2 (es) Receptores quiméricos de flt3 y métodos de uso de los mismos
EA201890817A1 (ru) Кристаллические формы бета-никотинамида мононуклеотида
IL257009A (en) Cells for immunotherapy engineered for targeting cd38 antigen and for cd38 gene inactivation
BR112018012873A2 (pt) vacina de vírus zika
MX387331B (es) Composiciones y metodos para induccion de celulas th17.
CL2016003096A1 (es) Métodos para cosechar cultivos de células de mamífero
MA49874A (fr) Vecteurs hvt recombinants exprimant de multiples antigènes de pathogènes aviaires, et vaccins les contenant
HUE045993T2 (hu) Emberi immunhiány vírus antigének, vektorok, készítmények és alkalmazásukra szolgáló eljárások
ZA202206809B (en) Hiv vaccines comprising one or more population episensus antigens
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
TN2013000378A1 (en) Anti - sclerostin antibody crystals and formulations thereof
CU24405B1 (es) Proteínas de variantes de secuencias de aminoácidos de cry1da1 activas para lepidópteros
MX2014001626A (es) Preservacion asistida con vacio de productos biologicos, en particular de vacunas.
MY191539A (en) Streptococcal vaccine
PH12016500500A1 (en) A viral vaccine and methods of manufacture thereof
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
PL3504225T3 (pl) Nowe antygeny białkowe otoczki ludzkiego wirusa niedoboru odporności eksprymowane przez ssaki
MA37749A1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
CY1118704T1 (el) Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου
MX392514B (es) Vacuna para estreptococo del grupo a.
MX2015013304A (es) Vacunas de nucleoproteina de la influenza.
MX2019007924A (es) Vacunas contra la influenza.